Working... Menu

Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke (ESS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00604630
Recruitment Status : Completed
First Posted : January 30, 2008
Last Update Posted : October 22, 2008
Johnson & Johnson
Information provided by:
Max-Planck-Institute of Experimental Medicine

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2008
  Actual Study Completion Date : June 2008

Publications automatically indexed to this study by Identifier (NCT Number):